🔎 Trials Near Me

Hjem › Koronararteriesykdom › Oklahoma

Kliniske studier for Koronararteriesykdom i Oklahoma

7 studier for Koronararteriesykdom søker deltakere på steder i Oklahoma.

Byer i Oklahoma

Offisiell studietekst (engelsk)

Pivotal Study of the SUpira System in Patients Undergoing High-Risk Percutaneous COronaRy InTervention (HRPCI)

  • Oklahoma Heart Hillcrest Medical, Tulsa
Rekrutterer
Alder 18 til 90 · Alle kjønn · Oppdatert 30. sep. 2026 · NCT07296744

Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention

  • South Oklahoma Heart Research, LLC, Oklahoma City
RekruttererFase 4
Alder 18 og eldre · Alle kjønn · Oppdatert 28. sep. 2026 · NCT06909565

A Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis

  • South Oklahoma Heart Research, LLC, Oklahoma City
RekruttererFase 2
Alder 18 til 80 · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07521007

Prospective Global Registry for the Study of Chronic Total Occlusion Intervention

  • Oklahoma City VA Medical Center, Oklahoma City
  • Oklahoma Heart Institute at Hillcrest Medical Center, Tulsa
RekruttererObservasjonsstudie
Alle aldre · Alle kjønn · Oppdatert 19. aug. 2026 · NCT02061436

MagicTouch™Sirolimus-Coated Balloon for Treatment of Coronary Artery Lesions in Small Vessels

  • University of Oklahoma Health Science Center, Oklahoma City
Rekrutterer
Alder 18 til 80 · Alle kjønn · Oppdatert 11. sep. 2025 · NCT06271590

Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve Replacement

  • Oklahoma Heart, Oklahoma City
Rekrutterer
Alle aldre · Alle kjønn · Oppdatert 24. jul. 2025 · NCT04634240

MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions

  • Oklahoma University Health (OU Health), Oklahoma City
Rekrutterer
Alder 18 til 110 · Alle kjønn · Oppdatert 25. feb. 2025 · NCT05908331

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.